Skip to main content

Want a detailed portfolio tracker?

RXST
NASDAQ
$5.61

RxSight Inc (RXST)

Rxsight Inc. is a cutting-edge healthcare technology company dedicated to transforming vision correction through advanced diagnostic and surgical solutions in refractive eye surgery. By integrating proprietary software with precision laser systems, Rxsight aims to significantly improve patient outcomes and enhance the quality of life for those seeking vision correction. The company boasts a robust intellectual property portfolio and strategic collaborations that position it favorably within the growing ophthalmic market. Committed to innovation and operational excellence, Rxsight is poised to drive substantial advancements in eye care, reflecting its potential for sustained growth and impact in the sector.
Website: https://rxsight.com
68 analysts
Hold
Target: $8.43 (+50.27%)

Market Cap

$217M

P/B Ratio

0.76

Revenue 5Y CAGR

+47.66%

Free Cash Flow Yield

-9.93%

Price Chart

Valuation
Market Cap$217M
Forward P/E116.28
P/S1.71
P/B0.76
Profitability
Total Revenue (TTM)$127M
Gross Profit (TTM)$98M
EBITDA-$52M
Profit Margin-51.4%
Operating Margin-57.7%
EPS-$1.13
Financial Health
Free Cash Flow Yield-9.93%
Growth & Risk
Revenue 5Y CAGR+47.66%
Beta (5Y)1.26
Sharpe Ratio-0.15